Standout Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies 2025 202616
  1. Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies (2025)
    Yan-Ruide Li, Ying Fang et al. Nature Communications

Immediate Impact

16 standout
Sub-graph 1 of 7

Citing Papers

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
2 intermediate papers

Works of Yichen Zhu being referenced

Mucosal-associated invariant T cells for cancer immunotherapy
2022
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
2022

Author Peers

Author Last Decade Papers Cites
Yichen Zhu 188 137 97 17 280
Ying Fang 160 115 87 16 231
Andrea Pepper 179 129 119 17 335
Mandy van Brakel 242 176 87 15 314
Ramizah Syahirah 113 176 119 11 307
Tommaso Sconocchia 109 87 79 20 235
Lemei Jia 187 120 117 12 288
Mi Shao 143 86 71 14 218
Katerina Goudevenou 204 160 92 10 282
Haven R. Garber 154 103 80 20 235
Seandean L. Harwood 159 113 163 21 332

All Works

Loading papers...

Rankless by CCL
2026